Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Starlite/ChEMBL | References |
Homo sapiens | ADAM metallopeptidase domain 17 | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 1 (interstitial collagenase) | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 14 (membrane-inserted) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Disintegrin family protein | ADAM metallopeptidase domain 17 | 824 aa | 724 aa | 27.4 % |
Brugia malayi | Matrixin family protein | matrix metallopeptidase 1 (interstitial collagenase) | 403 aa | 401 aa | 27.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.014 | 0.0922 | 0.0522 |
Schistosoma mansoni | loxhd1 | 0.014 | 0.0922 | 0.0522 |
Onchocerca volvulus | 0.0172 | 0.1337 | 0.3582 | |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0172 | 0.1346 | 0.0964 |
Echinococcus granulosus | geminin | 0.0179 | 0.1436 | 0.1058 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0317 | 0.323 | 0.2932 |
Schistosoma mansoni | alpha-glucosidase | 0.0148 | 0.1033 | 0.0638 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.0922 | 0.1772 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.014 | 0.0922 | 0.0522 |
Echinococcus granulosus | ankyrin repeat protein | 0.0311 | 0.3148 | 0.2846 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.0678 | 0.1302 |
Onchocerca volvulus | 0.014 | 0.0922 | 0.2471 | |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.014 | 0.0922 | 0.0522 |
Brugia malayi | Matrixin family protein | 0.0121 | 0.0678 | 0.1265 |
Schistosoma mansoni | hypothetical protein | 0.014 | 0.0922 | 0.0522 |
Brugia malayi | metalloprotease disintegrin 16 with thrombospondin type I motif | 0.0105 | 0.0472 | 0.0732 |
Schistosoma mansoni | rab6-interacting | 0.014 | 0.0922 | 0.0522 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 0.5205 | 1 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.014 | 0.0923 | 0.0523 |
Schistosoma mansoni | lipoxygenase | 0.0836 | 1 | 1 |
Echinococcus multilocularis | adam 17 protease | 0.0223 | 0.2005 | 0.1653 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.014 | 0.0922 | 0.0522 |
Brugia malayi | hypothetical protein | 0.0101 | 0.0422 | 0.0602 |
Brugia malayi | Hemopexin family protein | 0.0172 | 0.1337 | 0.2974 |
Onchocerca volvulus | Matrilysin homolog | 0.0121 | 0.0678 | 0.1816 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.014 | 0.0922 | 0.0522 |
Brugia malayi | Matrixin family protein | 0.038 | 0.4048 | 1 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.014 | 0.0922 | 0.0522 |
Schistosoma mansoni | hypothetical protein | 0.0172 | 0.1337 | 0.0955 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.014 | 0.0923 | 0.0523 |
Echinococcus multilocularis | ankyrin repeat protein | 0.0311 | 0.3148 | 0.2846 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.2166 | 0.4161 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.0133 | 0.0255 |
Loa Loa (eye worm) | hypothetical protein | 0.0208 | 0.1811 | 0.348 |
Brugia malayi | hypothetical protein | 0.014 | 0.0922 | 0.1899 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0172 | 0.1346 | 0.0964 |
Onchocerca volvulus | 0.01 | 0.0399 | 0.1069 | |
Onchocerca volvulus | 0.0121 | 0.0678 | 0.1816 | |
Brugia malayi | ADAM-TS Spacer 1 family protein | 0.0235 | 0.2166 | 0.5121 |
Onchocerca volvulus | 0.014 | 0.0922 | 0.2471 | |
Schistosoma mansoni | alpha-glucosidase | 0.0148 | 0.1033 | 0.0638 |
Schistosoma mansoni | hypothetical protein | 0.0367 | 0.3882 | 0.3612 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0147 | 0.1022 | 0.5 |
Schistosoma mansoni | transient receptor potential cation channel subfamily A member | 0.0311 | 0.3148 | 0.2846 |
Brugia malayi | Matrixin family protein | 0.0121 | 0.0678 | 0.1265 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0147 | 0.1022 | 0.5 |
Echinococcus granulosus | adam 17 protease | 0.0245 | 0.2295 | 0.1955 |
Onchocerca volvulus | Matrilysin homolog | 0.0355 | 0.3733 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0585 | 0.672 | 0.6576 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 0.0223 | 0.2005 | 0.1653 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0208 | 0.1811 | 0.145 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.0922 | 0.1772 |
Schistosoma mansoni | rab6-interacting | 0.014 | 0.0922 | 0.0522 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.014 | 0.0922 | 0.5 |
Schistosoma mansoni | polycystin 1-related | 0.014 | 0.0922 | 0.0522 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.1022 | 0.1963 |
Plasmodium falciparum | LCCL domain-containing protein | 0.014 | 0.0922 | 0.5 |
Brugia malayi | Matrixin family protein | 0.0121 | 0.0678 | 0.1265 |
Echinococcus granulosus | a disintegrin and metalloproteinase with | 0.0197 | 0.1663 | 0.1295 |
Loa Loa (eye worm) | matrixin family protein | 0.038 | 0.4048 | 0.7778 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0268 | 0.2599 | 0.6964 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.0678 | 0.1302 |
Trypanosoma brucei | RNA helicase, putative | 0.0367 | 0.3882 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.1436 | 0.1058 |
Brugia malayi | Doublecortin family protein | 0.014 | 0.0922 | 0.1899 |
Brugia malayi | Matrixin family protein | 0.0121 | 0.0678 | 0.1265 |
Echinococcus multilocularis | geminin | 0.0179 | 0.1436 | 0.1058 |
Loa Loa (eye worm) | doublecortin family protein | 0.014 | 0.0922 | 0.1772 |
Schistosoma mansoni | ADAMTS5 peptidase (M12 family) | 0.0197 | 0.1663 | 0.1295 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0527 | 0.597 | 0.5792 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0172 | 0.1346 | 0.0964 |
Mycobacterium ulcerans | hydrolase | 0.0147 | 0.1022 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.0268 | 0.2599 | 0.4994 |
Echinococcus multilocularis | RUN | 0.014 | 0.0922 | 0.0522 |
Brugia malayi | hypothetical protein | 0.014 | 0.0922 | 0.1899 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0147 | 0.1022 | 0.2156 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0172 | 0.1346 | 0.2586 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0836 | 1 | 1 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0317 | 0.323 | 0.2932 |
Loa Loa (eye worm) | matrix metalloproteinase | 0.0121 | 0.0678 | 0.1302 |
Echinococcus multilocularis | a disintegrin and metalloproteinase with | 0.0197 | 0.1663 | 0.1295 |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.1436 | 0.1058 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0527 | 0.597 | 0.5792 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0172 | 0.1346 | 0.2996 |
Echinococcus granulosus | RUN | 0.014 | 0.0922 | 0.0522 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.017 uM | Inhibition of human recombinant aggrecanase 2 after 150 mins by fluorescence plate reader | ChEMBL. | 21417219 |
IC50 (binding) | = 2.1 uM | Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader | ChEMBL. | 21417219 |
IC50 (binding) | = 6.3 uM | Inhibition of human recombinant TACE after 60 mins by fluorescence plate reader | ChEMBL. | 21417219 |
IC50 (binding) | > 10 uM | Inhibition of human recombinant MMP1 after 60 mins by fluorescence plate reader | ChEMBL. | 21417219 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.